Qube Research & Technologies LTD Pfizer Inc Call Options Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $46.3 Million - $52.5 Million	1,671,700 Added 295.14%	2,238,100 $64.8 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $992,718 - $1.16 Million	39,300 Added 7.46%	566,400 $15.8 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $9.23 Million - $10.6 Million	356,500 Added 208.97%	527,100 $14.6 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $1.35 Million - $1.75 Million	51,600 Added 43.36%	170,600 $4.91 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $3.82 Million - $4.46 Million	119,000 New	119,000 $3.95 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $8.35 Million - $10.9 Million	200,000 New	200,000 $10.3 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.